The U.S. Food and Drug Administration (FDA) has accepted for review ChemoCentryx‘s application requesting the approval of…
Articles by Joana Carvalho, PhD
The 20S-proteasome — the core of an enzyme complex responsible for eliminating unnecessary or damaged proteins in cells —…
Plasma exchange does not prolong the survival of patients with severe ANCA-associated vasculitis connected with diffuse alveolar…
A combination of rituximab, plus glucocorticoids, is highly effective at re-inducing remission in patients with relapsed ANCA-associated…
ChemoCentryx is asking the U.S. Food and Drug Administration (FDA) to approve avacopan, a potential oral treatment for people with…
The Vasculitis Foundation awarded its “Dr. Chris Cox-Marinelli Young Investigator Award” — a one-year research grant totaling $49,822 —…
InflaRx announced it has fully enrolled the first part of its Phase 2 trial assessing the safety and…
An instrument that assesses the nutritional status of individuals can be used to predict the prognosis of patients with…
Work productivity of people with ANCA-associated vasculitis is influenced by their disease activity, the extent of organ damage, and…
High levels of a small RNA molecule called miR-142-3p may impair the function of immune regulatory T-cells in people…